Visualizing language deterioration in progressive aphasias
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this issue of Neurology, Gorno-Tempini et al.1 and Rosen et al.2 present studies characterizing neuroimaging and behavioral changes in subtypes of primary progressive aphasia (PPA). They add new information to a large and growing body of literature on the frontotemporal lobar degenerations (FTLD), the second most common cause of dementia in persons under age 65. As this group of illnesses is still less common than other causes of dementia, such as Alzheimer disease (AD) and vascular dementia, both studies were made possible through the systematic study of a large number of such patients performed at a tertiary referral center.
In order to explore the anatomic basis for mutism in progressive nonfluent aphasia (PNFA), one form of FTLD, Gorno-Tempini et al.1 compared gray matter volumes in regions of interest between mute and non-mute patients with PNFA using voxel-based morphometry. Many patients with PNFA eventually develop mutism so it is important to note that patients and controls in this study were matched for disease duration. These investigators found more severe atrophy in the left anterior insula and inferior frontal lobe in persons with PNFA with more prominent atrophy in the pars opercularis and underlying basal ganglia in …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Views and Reviews
Classification of primary progressive aphasia and its variantsM.L. Gorno-Tempini, A.E. Hillis, S. Weintraub et al.Neurology, February 16, 2011 -
Articles
Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasiaW.T. Hu, C. McMillan, D. Libon et al.Neurology, August 16, 2010 -
Articles
Prediction of pathology in primary progressive language and speech disordersV. Deramecourt, F. Lebert, B. Debachy et al.Neurology, November 25, 2009 -
Articles
Behavioral features in semantic dementia vs other forms of progressive aphasiasH. J. Rosen, S. C. Allison, J. M. Ogar et al.Neurology, November 27, 2006